Literature DB >> 19775491

Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.

J-P Vercruysse1, B De Foer, T Somers, J Casselman, E Offeciers.   

Abstract

OBJECTIVE: The canal wall up bony obliteration technique lowers the incidence of recurrent cholesteatoma, but carries the potential risk of obliterating residual cholesteatoma. The objective of this study was to report long-term follow-up radiological findings after performing a canal wall up bony obliteration technique procedure, in order to detect residual and/or recurrent cholesteatoma. PATIENTS: Fifty-one patients presenting with a cholesteatoma or a troublesome cavity were operated upon using the canal wall up bony obliteration technique, and were evaluated by follow-up imaging a mean of 76.4 months post-operatively (range, 53.8-113.6 months). INTERVENTION: All patients were evaluated with high resolution computed tomography and magnetic resonance imaging (including delayed contrast, T1-weighted imaging and non-echo-planar, diffusion-weighted imaging).
RESULTS: Imaging revealed the presence of one residual, one recurrent and one congenital petrosal apex cholesteatoma. On high resolution computed tomography, completely obliterated mastoid filled with bone was observed in 74.5 per cent (38/51) of patients, and an aerated middle-ear cavity in 64.7 per cent (33/51). High resolution computed tomography clearly detected any associated soft tissue present in the middle-ear cavity (18/51) and in the obliterated mastoids (13/51), but could not characterise this tissue. Non-echo-planar, diffusion-weighted magnetic resonance imaging clearly identified all three cholesteatomas, and differentiated them from other associated soft tissues. No cholesteatoma was found within the obliterated mastoids.
CONCLUSION: Long-term follow up indicated that the canal wall up bony obliteration technique is a safe method with which to treat primary and recurrent cholesteatoma and to reconstruct unstable cavities. Soft tissue was found quite often in the middle ear and obliterated mastoids. High resolution computed tomography identified its presence but could not further characterise it. However, non-echo-planar, diffusion-weighted magnetic resonance imaging succeeded in differentiating soft tissues, enabling detection of residual or recurrent cholesteatoma after a canal wall up bony obliteration technique procedure.

Entities:  

Mesh:

Year:  2009        PMID: 19775491     DOI: 10.1017/S002221510999106X

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

Review 1.  Diffusion-weighted magnetic resonance imaging of the temporal bone.

Authors:  B De Foer; J-P Vercruysse; M Spaepen; T Somers; M Pouillon; E Offeciers; J W Casselman
Journal:  Neuroradiology       Date:  2010-07-15       Impact factor: 2.804

2.  Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.

Authors:  Daniele Bernardeschi; Bruno Law-Ye; Franck Bielle; Baptiste Hochet; Olivier Sterkers; Didier Dormont; Nadya Pyatigorskaya
Journal:  Eur Radiol       Date:  2019-03-19       Impact factor: 5.315

3.  Health Related Quality of Life after the Bony Obliteration Tympanoplasty for COM with Cholesteatoma using the COMQ12 - A Disease Specific PROM.

Authors:  Wouter Baetens; Joost van Dinther; Robby Vanspauwen; Youri Maryn; Andrzej Zarowski; Erwin Offeciers
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

4.  Mid-term outcomes of mastoid obliteration with biological hydroxyapatite versus bioglass: a radiological and clinical study.

Authors:  Sonia Sahli-Vivicorsi; Zarrin Alavi; William Bran; Romain Cadieu; Philippe Meriot; Jean-Christophe Leclere; Rémi Marianowski
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-17       Impact factor: 3.236

Review 5.  A review of current progress in acquired cholesteatoma management.

Authors:  Chin-Lung Kuo; Wen-Huei Liao; An-Suey Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

6.  Canal wall reconstruction in cholesteatoma surgeries: rate of residual.

Authors:  A Roux; D Bakhos; E Lescanne; J-P Cottier; A Robier
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

7.  Hearing and hearing rehabilitation after obliteration of troublesome mastoid cavities.

Authors:  Simon Geerse; Tim J M Bost; Samira Allagul; Maarten J F de Wolf; Fenna A Ebbens; Erik van Spronsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-22       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.